Acetazolamide sodium and Epilepsy - a phase IV clinical study of FDA data

Summary:

Epilepsy is reported as a side effect among people who take Acetazolamide sodium (acetazolamide sodium), especially for people who are female, also take Alphagan P,.

The phase IV clinical study analyzes which people have Epilepsy when taking Acetazolamide sodium. It is created by eHealthMe based on reports of 120 people who have side effects when taking Acetazolamide sodium from the FDA, and is updated regularly.

What is Acetazolamide sodium?

Acetazolamide sodium has active ingredients of acetazolamide sodium. eHealthMe is studying from 138 Acetazolamide sodium users. Check the latest studies of Acetazolamide sodium.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,166 drugs and 1,779 conditions by eHealthMe. Check the latest studies of Epilepsy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 31, 2026

120 people reported to have side effects when taking Acetazolamide sodium.
Among them, 18 people (15.0%) have Epilepsy.

Could Acetazolamide sodium cause Epilepsy?

Among these 18 people:

What is the gender of people who have Epilepsy when taking Acetazolamide sodium? *

female: 100 %
male: 0.0 %

What are other drugs people take besides Acetazolamide sodium? *

Remicade: 18 people, 100.00%
Humira: 18 people, 100.00%
Alphagan P: 18 people, 100.00%
Imuran: 17 people, 94.44%
Myfortic: 15 people, 83.33%
Amlodipine: 15 people, 83.33%
Pred Forte: 5 people, 27.78%
Dorzolamide Hydrochloride And Timolol Maleate: 5 people, 27.78%
Latanoprost: 4 people, 22.22%
Colchicine: 4 people, 22.22%

What are other side effects people have besides Epilepsy? *

Vitamin D Decreased: 18 people, 100.00%
High Blood Pressure: 18 people, 100.00%
Cough: 18 people, 100.00%
Cutaneous Vasculitis (an inflammatory process affecting the vessel wall that leads to its damage): 18 people, 100.00%
Drug Ineffective: 18 people, 100.00%
Dyslipidaemia (abnormal amount of lipids): 18 people, 100.00%
Fever: 18 people, 100.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 18 people, 100.00%
Inflammation: 18 people, 100.00%
Sinusitis (inflammation of sinus): 18 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide sodium and have Epilepsy?

- Check whether Epilepsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetazolamide sodium:

Acetazolamide sodium (138 reports)

Epilepsy treatments and more:

Epilepsy (129,286 reports)

Browse all side effects of Acetazolamide sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy:

Epilepsy (1,166 drugs)

Browse all the conditions that are associated with Epilepsy:

Epilepsy (1,779 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide sodium (the active ingredients of Acetazolamide sodium) and Acetazolamide sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.